$2.35 Billion is the total value of SECTORAL ASSET MANAGEMENT INC's 75 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 26.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GILD | Sell | GILEAD SCIENCES INC | $180,351,000 | -1.1% | 1,782,298 | -4.0% | 7.69% | -7.9% |
| ALXN | Buy | ALEXION PHARM INC | $144,623,000 | +28.2% | 758,180 | +5.1% | 6.17% | +19.3% |
| BMRN | Buy | BIOMARIN PHARMAC INC | $142,465,000 | +39.5% | 1,359,922 | +40.2% | 6.07% | +29.8% |
| CELG | Sell | CELGENE CORP | $140,964,000 | +2.8% | 1,177,058 | -7.1% | 6.01% | -4.3% |
| REGN | Sell | REGENERON PHARMCTCLS | $128,280,000 | +13.0% | 236,300 | -3.2% | 5.47% | +5.2% |
| INCY | Buy | INCYTE CORPORATION | $122,269,000 | +24.9% | 1,127,423 | +27.1% | 5.21% | +16.3% |
| BIIB | Sell | BIOGEN INC | $89,114,000 | -51.1% | 290,889 | -53.5% | 3.80% | -54.5% |
| VRTX | Sell | VERTEX PHARMACEUTICALS | $86,596,000 | +13.3% | 688,200 | -6.3% | 3.69% | +5.4% |
| TMO | Buy | THERMO FISHER SCI | $86,094,000 | +16.3% | 606,936 | +0.2% | 3.67% | +8.2% |
| AMGN | Sell | AMGEN INC | $81,911,000 | +6.8% | 504,597 | -9.0% | 3.49% | -0.7% |
| FOLD | Buy | AMICUS THERAPEUTICS | $77,342,000 | -9.5% | 7,973,436 | +30.5% | 3.30% | -15.8% |
| MRK | Buy | MERCK & CO INC | $59,260,000 | +9.3% | 1,121,925 | +2.2% | 2.53% | +1.8% |
| SGEN | Buy | SEATTLE GENETICS INC | $57,257,000 | +17.0% | 1,275,775 | +0.5% | 2.44% | +8.9% |
| XLRN | Buy | ACCELERON PHARMA | $54,673,000 | +258.7% | 1,121,264 | +83.2% | 2.33% | +234.0% |
| PTCT | Buy | PTC THERAPEUTICS I | $51,395,000 | +178.8% | 1,586,258 | +129.8% | 2.19% | +159.6% |
| LLY | New | ELI LILLY & CO | $50,492,000 | – | 599,245 | +100.0% | 2.15% | – |
| MDT | Buy | MEDTRONIC PLCshares | $41,828,000 | +18.8% | 543,792 | +3.4% | 1.78% | +10.5% |
| TEVA | Buy | TEVA PHARMACEUTICALadr | $39,773,000 | +18.4% | 605,922 | +1.8% | 1.70% | +10.2% |
| HALO | Sell | HALOZYME THERAPEUTIC | $35,974,000 | +0.3% | 2,075,796 | -22.3% | 1.53% | -6.6% |
| SHPG | Buy | SHIRE PLCsp adr | $33,758,000 | +34.8% | 164,674 | +34.9% | 1.44% | +25.3% |
| ICPT | Buy | INTERCEPT PHARMACE | $32,864,000 | -9.8% | 220,047 | +0.2% | 1.40% | -16.1% |
| MYL | Buy | MYLAN N V | $32,545,000 | +93.8% | 601,910 | +44.3% | 1.39% | +80.5% |
| ALDR | Buy | ALDER BIOPHARMACEU | $30,881,000 | +23.6% | 934,951 | +22.6% | 1.32% | +15.0% |
| UTHR | Buy | UNITED THERAPEUTICS | $30,583,000 | +32.6% | 195,280 | +11.1% | 1.30% | +23.4% |
| DXCM | Buy | DEXCOM INC | $29,708,000 | +7.0% | 362,733 | +12.2% | 1.27% | -0.3% |
| ALGN | Sell | ALIGN TECH INC | $25,425,000 | -12.6% | 386,104 | -24.6% | 1.08% | -18.6% |
| UNH | Buy | UNITEDHEALTH GRP INC | $24,663,000 | +11.2% | 209,648 | +9.7% | 1.05% | +3.5% |
| STJ | Buy | ST JUDE MEDICAL INC | $24,533,000 | +9.6% | 397,161 | +11.9% | 1.05% | +1.9% |
| NBIX | New | NEUROCRINE BIOSCIENC | $23,572,000 | – | 416,680 | +100.0% | 1.00% | – |
| OPHT | New | OPHTHOTECH CORP | $22,688,000 | – | 288,906 | +100.0% | 0.97% | – |
| TSRO | New | TESARO INC | $21,193,000 | – | 405,069 | +100.0% | 0.90% | – |
| CARA | Buy | CARA THERAPEUTICS | $20,444,000 | +39.8% | 1,212,578 | +18.5% | 0.87% | +30.1% |
| EW | Buy | EDWARDS LIFESCIENCE | $19,768,000 | -9.2% | 250,295 | +63.5% | 0.84% | -15.4% |
| QURE | Buy | UNIQURE N.V.shares | $18,831,000 | +20.9% | 1,138,513 | +49.4% | 0.80% | +12.5% |
| TGTX | Buy | TG THERAPEUTICS | $18,153,000 | +23.0% | 1,521,667 | +3.9% | 0.77% | +14.5% |
| AIMT | Buy | AIMMUNE THERAPEUTICS | $18,120,000 | -9.7% | 982,133 | +23.9% | 0.77% | -15.9% |
| ADXS | Buy | ADVAXIS INC | $18,015,000 | +39.4% | 1,790,715 | +41.7% | 0.77% | +29.7% |
| IMDZ | Buy | IMMUNE DESIGN CORP | $17,206,000 | +66.7% | 856,867 | +1.3% | 0.73% | +55.2% |
| ISRG | Buy | INTUITIVE SURGIC INC | $16,947,000 | +53.0% | 31,030 | +28.8% | 0.72% | +42.6% |
| NVO | Buy | NOVO-NORDISK ASadr | $16,093,000 | +26.1% | 277,075 | +17.7% | 0.69% | +17.3% |
| NXTM | Sell | NXSTAGE MEDICAL | $15,366,000 | +36.8% | 701,303 | -1.5% | 0.66% | +27.2% |
| NVS | Buy | NOVARTIS AGsp adr | $15,350,000 | +14.9% | 178,405 | +22.8% | 0.65% | +6.9% |
| DNAI | Buy | PRONAI THERAPEUTICS | $14,386,000 | -16.8% | 910,566 | +5.5% | 0.61% | -22.6% |
| SGNT | Buy | SAGENT PHARMACEUTI | $12,893,000 | +43.6% | 810,362 | +38.4% | 0.55% | +33.8% |
| TDOC | Buy | TELADOC INC | $10,369,000 | +11.4% | 577,361 | +38.2% | 0.44% | +3.5% |
| HTWR | Sell | HEARTWARE INTL INC | $10,282,000 | -12.5% | 204,008 | -9.2% | 0.44% | -18.6% |
| ADPTQ | New | ADEPTUS HEALTH INCcl a | $10,236,000 | – | 187,744 | +100.0% | 0.44% | – |
| ACHC | Buy | ACADIA HEALTHCARE | $9,922,000 | +16.9% | 158,852 | +24.1% | 0.42% | +8.7% |
| IONS | New | IONIS PHARMACEUTICAL | $9,290,000 | – | 150,000 | +100.0% | 0.40% | – |
| CI | Buy | CIGNA CORP | $8,356,000 | +10.7% | 57,104 | +2.1% | 0.36% | +2.9% |
| AGN | Sell | ALLERGAN PLCshares | $6,310,000 | -83.7% | 20,192 | -85.8% | 0.27% | -84.8% |
| RGNX | Sell | REGENXBIO INC | $5,822,000 | -46.3% | 350,700 | -30.9% | 0.25% | -50.0% |
| RDY | Sell | DR REDDYS LABS LTDadr | $5,628,000 | -65.5% | 121,586 | -52.3% | 0.24% | -67.8% |
| CMRX | Buy | CHIMERIX INC | $4,923,000 | -73.0% | 550,100 | +15.4% | 0.21% | -74.8% |
| PRGO | Buy | PERRIGO COshares | $4,315,000 | +2.2% | 29,821 | +11.0% | 0.18% | -5.2% |
| MNKKQ | Buy | MALLINCKRODT PLCshares | $3,967,000 | +62.2% | 53,154 | +39.0% | 0.17% | +50.9% |
| New | REGENXBIO INC | $3,108,000 | – | 156,741 | +100.0% | 0.13% | – | |
| MNTA | Buy | MOMENTA PHARMACEUTIC | $2,845,000 | +15.3% | 191,737 | +27.5% | 0.12% | +7.1% |
| AKRXQ | Sell | AKORN INC | $2,403,000 | +23.0% | 64,403 | -6.0% | 0.10% | +14.6% |
| NKTR | Buy | NEKTAR THERAPEUTICS | $2,311,000 | +102.0% | 137,127 | +31.3% | 0.10% | +90.4% |
| ALKS | Sell | ALKERMES PLCshares | $2,056,000 | +16.8% | 25,895 | -13.7% | 0.09% | +8.6% |
| MCK | Buy | MCKESSON CORP | $2,051,000 | +20.2% | 10,401 | +12.8% | 0.09% | +11.5% |
| IPXL | Sell | IMPAX LABS INC | $2,011,000 | +9.2% | 47,031 | -10.1% | 0.09% | +2.4% |
| EGRX | Sell | EAGLE PHARMACEUTIC | $1,942,000 | -6.8% | 21,899 | -22.2% | 0.08% | -12.6% |
| JAZZ | Buy | JAZZ PHARMA PLC | $1,905,000 | +15.6% | 13,550 | +9.2% | 0.08% | +8.0% |
| ENDP | Buy | ENDO INTL PLCshares | $1,902,000 | +11.4% | 31,062 | +26.1% | 0.08% | +3.8% |
| DEPO | Buy | DEPOMED INC | $1,689,000 | +24.5% | 93,183 | +29.4% | 0.07% | +16.1% |
| CTLT | Buy | CATALENT INC | $1,533,000 | +224.1% | 61,234 | +214.8% | 0.06% | +195.5% |
| CBM | Buy | CAMBREX CORP | $1,188,000 | +94.8% | 25,231 | +64.2% | 0.05% | +82.1% |
| AMPH | Buy | AMPHASTAR PHARMACTLS | $1,035,000 | +111.7% | 72,753 | +74.1% | 0.04% | +100.0% |
| IRWD | New | IRONWOOD PHARMACEUCL | $948,000 | – | 81,762 | +100.0% | 0.04% | – |
| CBPO | Sell | CHINA BIOLOGIC PROD | $839,000 | +36.6% | 5,890 | -13.9% | 0.04% | +28.6% |
| PRFMF | New | PROFOUND MEDICAL | $594,000 | – | 1,031,700 | +100.0% | 0.02% | – |
| ASND | ASCENDIS PHARMA A Ssp adr | $570,000 | +3.6% | 31,100 | 0.0% | 0.02% | -4.0% | |
| CHRS | Sell | COHERUS BIOSCIENCES | $366,000 | +10.6% | 15,940 | -3.4% | 0.02% | +6.7% |
| PCRX | Exit | PACIRA PHARMACEUTICALS | $0 | – | -18,357 | -100.0% | -0.04% | – |
| HZNP | Exit | HORIZON PHARMAshares | $0 | – | -67,852 | -100.0% | -0.06% | – |
| LCI | Exit | LANNETT CO INC | $0 | – | -33,793 | -100.0% | -0.06% | – |
| OMED | Exit | ONCOMED PHARMACEUTICALS | $0 | – | -109,211 | -100.0% | -0.08% | – |
| ZSPH | Exit | ZS PHARMA INC | $0 | – | -42,000 | -100.0% | -0.13% | – |
| VRX | Exit | VALEANT PHARMA INTL | $0 | – | -17,839 | -100.0% | -0.15% | – |
| TTPH | Exit | TETRAPHASE PHARMACEUTICALS | $0 | – | -692,036 | -100.0% | -0.24% | – |
| KPTI | Exit | KARYOPHARM THERAPEUTICS | $0 | – | -712,968 | -100.0% | -0.34% | – |
| RLYP | Exit | RELYPSA INC | $0 | – | -842,030 | -100.0% | -0.71% | – |
| PTLA | Exit | PORTOLA PHARMACEUTICALS | $0 | – | -1,088,118 | -100.0% | -2.12% | – |
| PFE | Exit | PFIZER INC | $0 | – | -1,711,016 | -100.0% | -2.46% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-02-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.